AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Food Science and Human Wellness Article
PDF (1.2 MB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

Lunasin protease inhibitor concentrate decreases pro-inflammatory cytokines and improves histopathological markers in dextran sodium sulfate-induced ulcerative colitis

Andrea Nieto-Velozaa, Zhihong Wanga, Qixin Zhonga, Doris D’Souzaa, Hari B. Krishnanb, Vermont P. Diaa( )
Department of Food Science, University of Tennessee, Knoxville 37996, USA
Agricultural Research Service, USDA, Columbia 65211, USA

Peer review under responsibility of KeAi Communications Co., Ltd.

Show Author Information

Abstract

Lunasin protease inhibitor concentrate (LPIC) is a novel combination of soy bioactive peptide lunasin, Kunitz and Bowman-Birk protease inhibitors. The reported anti-inflammatory and anticancer properties of each one of them suggest LPIC as a promising candidate for the treatment of inflammatory-related diseases. Our objective was to assess the in vivo anti-inflammatory properties of LPIC. First, an in vitro test was performed in lipopolysaccharide (LPS)-activated RAW264.7 murine macrophages by measuring the production of nitric oxide (NO), interleukin-6 (IL-6), and tumor necrosis factor α (TNF-α) as inflammatory markers. For the in vivo model, ulcerative colitis (UC) was induced in mice via oral administration of dextran sodium sulfate (DSS). LPIC treatment was performed via daily intraperitoneal injection of 50 mg/kg body weight. Body weight, visible blood in stool and stool consistency were scored daily as macroscopic indicators of disease progression. Occult blood was evaluated by the presence of hemoglobin in stool every third day. Colon length, caecum weight, colonic myeloperoxidase activity (MPO), presence of pro-inflammatory cytokines in blood and colon, changes in the architecture, and expression of inducible nitric oxide synthase (iNOS) in colonic tissue were evaluated. In vitro, LPIC induced production of NO and maintained cytokine levels in comparison to activated untreated macrophages. In vivo, LPIC increased colonic bleeding and did not improve macroscopic markers of the disease, but reduced colonic IL-1β and IL-6, decreased systemic circulation of TNF-α, attenuated neutrophils infiltration and iNOS expression in colonic tissue, and diminished the damage in colonic architecture. Our results suggest that combinations of peptides in LPIC may counteract the anti-inflammatory properties in vitro; while in vivo, LPIC can significantly reduce the histopathological damage, hence is a possible therapeutic strategy to attenuate UC.

Keywords

InflammationCytokinesUlcerative colitisBio-peptidesProtease inhibitor

References

[1]

H. Shigetomi, A. Onogi, H. Kajiwara, et al., Anti-inflammatory actions of serine protease inhibitors containing the Kunitz domain, Inflamm. Res. 59 (2010) 679-687. https://doi.org/10.1007/s00011-010-0205-5.
Crossref Google Scholar
[2]

M. Taniguchi, R. Aida, K. Saito, et al., Identification and characterization of multifunctional cationic peptides from enzymatic hydrolysates of soybean proteins, J. Biosci. Bioeng. 129 (2020) 59-66. https://doi.org/10.1016/j.jbiosc.2019.06.016.
Crossref Google Scholar
[3]

Y. Xu, P. Zhang, X. Liu, et al., Preparation and irreversible inhibition mechanism insight into a recombinant Kunitz trypsin inhibitor from Glycine max L, Seeds 91 (2020) 1207-1222. https://doi.org/10.1007/s12010-020-03254-5.
Crossref Google Scholar
[4]

F. Safavi, A. Rostami, Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases, Exp. Mol. Pathol. 93 (2012) 428-433. https://doi.org/10.1016/j.yexmp.2012.09.014.
Crossref Google Scholar
[5]

J.K.C. Ribeiro, D.D.S. Cunha, J.M.S.L.L. Fook, et al., New properties of the soybean trypsin inhibitor: inhibition of human neutrophil elastase and its effect on acute pulmonary injury, Eur. J. Pharmacol. 644 (2010) 238-244. https://doi.org/10.1016/j.ejphar.2010.06.067.
Crossref Google Scholar
[6]

S. Fernández-Tomé, B. Hernández-Ledesma, Current state of art after twenty years of the discovery of bioactive peptide lunasin, Food Res. Int. 116 (2019) 71-78. https://doi.org/10.1016/j.foodres.2018.12.029.
Crossref Google Scholar
[7]

B. Hernández-Ledesma, C.C. Hsieh, B.O. de Lumen, Antioxidant and anti-inflammatory properties of cancer preventive peptide lunasin in RAW264.7 macrophages, Biochem. Biophys. Res. Commun. 390 (2009) 803-808. https://doi.org/10.1016/j.bbrc.2009.10.053.
Crossref Google Scholar
[8]

V.P. Dia, W. Wang, V.L. Oh, et al., Isolation, purification and characterisation of lunasin from defatted soybean flour and in vitro evaluation of its anti-inflammatory activity, Food Chem. 114 (2009) 108-115. https://doi.org/10.1016/j.foodchem.2008.09.023.
Crossref Google Scholar
[9]

H.B. Krishnan, T.T.Y. Wang, An effective and simple procedure to isolate abundant quantities of biologically active chemopreventive Lunasin protease inhibitor concentrate (LPIC) from soybean, Food Chem. 177 (2015) 120-126. https://doi.org/10.1016/j.foodchem.2015.01.006.
Crossref Google Scholar
[10]

M. Zeeshan, H. Ali, S. Khan, et al., Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease, Int. J. Pharm. 558 (2019) 201-214. https://doi.org/10.1016/j.ijpharm.2018.12.074.
Crossref Google Scholar
[11]

R. Francescone, V. Hou, S.I. Grivennikov, Cytokines, IBD, and colitis-associated cancer, Inflamm. Bowel Dis. 21 (2015) 409-418. https://doi.org/10.1097/MIB.0000000000000236.
Crossref Google Scholar
[12]

K. Head, J. Jurenka, Inflammatory bowel disease part I: ulcerative colitis - pathophysiology and conventional and alternative treatment options, Altern. Med. 8(3) (2003) 247-283.
Google Scholar
[13]

B. Zhang, A. Gulati, O. Alipour, et al., Relapse from deep remission after therapeutic de-escalation in inflammatory bowel disease: a systematic review and meta-analysis, J. Crohn’s Colitis. 14(10) (2020) 1413-1423. https://doi.org/10.1093/ecco-jcc/jjaa087.
Crossref Google Scholar
[14]

A. Nieto-Veloza, Z. Wang, Q. Zhong, et al., BG-4 from bitter gourd (Momordica charantia) differentially affects inflammation in vitro and in vivo, Antioxidants 8 (2019) 175. https://doi.org/10.3390/antiox8060175.
Crossref Google Scholar
[15]

R. Minhas, Y. Bansal, G. Bansal, Inducible nitric oxide synthase inhibitors: a comprehensive update, Med. Res. Rev. 40 (2020) 823-855. https://doi.org/10.1002/med.21636.
Crossref Google Scholar
[16]

T.J. McCabe, D. Fulton, L.J. Roman, et al., Enhanced electron flux and reduced calmodulin dissociation may explain “calcium-independent” eNOS activation by phosphorylation, J. Biol. Chem. 275 (2000) 6123-6128. https://doi.org/10.1074/jbc.275.9.6123.
Crossref Google Scholar
[17]

C. Schirra, N. Xia, A. Schüffler, et al., Phosphorylation and activation of endothelial nitric oxide synthase by red fruit (Pandanus conoideus Lam) oil and its fractions, J. Ethnopharmacol. 251 (2020) 112534. https://doi.org/10.1016/j.jep.2019.112534.
Crossref Google Scholar
[18]

L. Connelly, A.T. Jacobs, M. Palacios-Callender, et al., Macrophage endothelial nitric-oxide synthase autoregulates cellular activation and pro-inflammatory protein expression, J. Biol. Chem. 278 (2003) 26480-26487. https://doi.org/10.1074/jbc.M302238200.
Crossref Google Scholar
[19]

C.Y. Tung, D.E. Lewis, L. Han, et al., Activation of dendritic cell function by soypeptide lunasin as a novel vaccine adjuvant, Vaccine 32 (2014) 5411-5419. https://doi.org/10.1016/j.vaccine.2014.07.103.
Crossref Google Scholar
[20]

H.C. Chang, D. Lewis, C.Y. Tung, et al., Soypeptide lunasin in cytokine immunotherapy for lymphoma, Cancer Immunol. Immunother. 63 (2014) 283-295. https://doi.org/10.1007/s00262-013-1513-8.
Crossref Google Scholar
[21]

P.A. Vo, B. Lad, J.A.P. Tomlinson, et al., Autoregulatory role of endothelium-derived nitric oxide (NO) on lipopolysaccharide-induced vascular inducible NO synthase expression and function, J. Biol. Chem. 280 (2005) 7236-7243. https://doi.org/10.1074/jbc.M411317200.
Crossref Google Scholar
[22]

L. Connelly, M. Palacios-Callender, C. Ameixa, et al., Biphasic regulation of NF-κB activity underlies the pro- and anti-inflammatory actions of nitric oxide, J. Immunol. 166 (2001) 3873-3881. https://doi.org/10.4049/jimmunol.166.6.3873.
Crossref Google Scholar
[23]

S.J. Price, P. Pangloli, H.B. Krishnan, et al., Kunitz trypsin inhibitor in addition to Bowman-Birk inhibitor influence stability of lunasin against pepsin-pancreatin hydrolysis, Food Res. Int. 90 (2016) 205-215. https://doi.org/10.1016/j.foodres.2016.10.051.
Crossref Google Scholar
[24]

E.Di Cera, Thrombin, Mol. Aspects Med. 29 (2008) 203-254. https://doi.org/10.1016/j.mam.2008.01.001.
Crossref Google Scholar
[25]

J. Wojta, Macrophages and thrombin-another link between inflammation and coagulation, Thromb. Haemost. 120 (2020) 537. https://doi.org/10.1055/s-0040-1708551.
Crossref Google Scholar
[26]

L.C. Burzynski, M. Humphry, K. Pyrillou, et al., The coagulation and immune systems are directly linked through the activation of interleukin-1α by thrombin, Immunity 50 (2019) 1033-1042. https://doi.org/10.1016/j.immuni.2019.03.003.
Crossref Google Scholar
[27]

V.P. Dia, H.B. Krishnan, BG-4, a novel anticancer peptide from bitter gourd (Momordica charantia), promotes apoptosis in human colon cancer cells, Sci. Rep. 6 (2016) 1-12. https://doi.org/10.1038/srep33532.
Crossref Google Scholar
[28]

J.P. Motta, A. Denadai-Souza, D. Sagnat, et al., Active thrombin produced by the intestinal epithelium controls mucosal biofilms, Nat. Commun. 10 (2019) 1-12. https://doi.org/10.1038/s41467-019-11140-w.
Crossref Google Scholar
[29]

S. Kitajima, S. Takuma, M. Morimoto, Tissue distribution of dextran sulfate sodium (DSS) in the acute phase of murine DSS-induced colitis, J. Vet. Med. Sci. 61(1) (1999) 67-70. https://doi.org/10.1292/jvms.61.67.
Crossref Google Scholar
[30]

N.M. Moreau, C.S. Toquet, C.L. Laboisse, et al., Predominance of caecal injury in a new dextran sulphate sodium treatment in rats: histopathological and fermentative characteristics, Eur. J. Gastroenterol. Hepatol. 14 (2002) 535-542. https://doi.org/10.1097/00042737-200205000-00011.
Crossref Google Scholar
[31]
J.J. O’Shea, M. Gadina, R.M. Siegel (Ed.), Clinical Immunology (Fifth Edition): 9-Cytokines and Cytokine Receptors, Elsevier Ltd, 2019, pp. 127-155. https://doi.org/10.1016/B978-0-7020-6896-6.00009-0.
Crossref
[32]

E.G. de Mejia, V.P. Dia, Lunasin and lunasin-like peptides inhibit inflammation through suppression of NF-κB pathway in the macrophage, Peptides 30 (2009) 2388-2398. https://doi.org/10.1016/j.peptides.2009.08.005.
Crossref Google Scholar
[33]

V.P. Dia, M.A. Berhow, E.G.De Mejia, Bowman-Birk inhibitor and genistein among soy compounds that synergistically inhibit nitric oxide and prostaglandin E2 pathways in lipopolysaccharide-induced macrophages, J. Agric. Food Chem. 56 (2008) 11707-11717. https://doi.org/10.1021/jf802475z.
Crossref Google Scholar
[34]

H. Kobayashi, R. Yoshida, Y. Kanada, et al., Suppression of lipopolysaccharide-induced cytokine production of gingival fibroblasts by a soybean, Kunitz trypsin inhibitor, J. Periodontal Res. 40 (2005) 461-468. https://doi.org/10.1111/j.1600-0765.2005.00824.x.
Crossref Google Scholar
[35]

M.F. Neurath, Cytokines in inflammatory bowel disease, Nat. Rev. Immunol. 14 (2014) 329-342. https://doi.org/10.1038/nri3661.
Crossref Google Scholar
[36]

Y. Aratani, Myeloperoxidase: its role for host defense, inflammation, and neutrophil function, Arch. Biochem. Biophys. 640 (2018) 47-52. https://doi.org/10.1016/j.abb.2018.01.004.
Crossref Google Scholar
[37]

R.N.N. Gamage, K.D.K.P. Kumari, A review on therapeutic potential of protease inhibitors from medicinal plants, Asian J. Res. Biochem. 3 (2019) 1-11. https://doi.org/10.9734/ajrb/2018/v3i430055.
Crossref Google Scholar
[38]

A. Clemente, M. Del, C. Arques, Bowman-Birk inhibitors from legumes as colorectal chemopreventive agents, World J. Gastroenterol. 20 (2014) 10305-10315. https://doi.org/10.3748/wjg.v20.i30.10305.
Crossref Google Scholar
Food Science and Human Wellness
Volume 11 Issue 6,
November 2022
Pages 1508-1514
DOI: 10.1016/j.fshw.2022.06.008
Cite this article:
Nieto-Veloza A, Wang Z, Zhong Q, et al. Lunasin protease inhibitor concentrate decreases pro-inflammatory cytokines and improves histopathological markers in dextran sodium sulfate-induced ulcerative colitis. Food Science and Human Wellness, 2022, 11(6): 1508-1514. https://doi.org/10.1016/j.fshw.2022.06.008

487

Views

44

Downloads

11

Crossref

10

Web of Science

10

Scopus

0

CSCD

Altmetrics
Received: 15 June 2020
Revised: 01 November 2020
Accepted: 04 November 2020
Published: 18 July 2022
© 2022 Beijing Academy of Food Sciences.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Return